Proteins of the XMRV retrovirus implicated in chronic fatigue syndrome and prostate cancer are homologous to human proteins relevant to both diseases. by Christopher Carter
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Proteins of the XMRV retrovirus implicated in chronic fatigue syndrome and prostate 









 The XMRV retrovirus has been implicated in chronic fatigue syndrome and 
prostate cancer. A homology search comparing retroviral with human proteins 
revealed short contiguous amino acid strings (typically 5-8 aa) matching human 
proteins whose dysfunction might be expected to cause fatigue, including 
mitochondrial proteins related to oxidative phosphorylation, glutamate receptors and 
their synaptic scaffolds, muscular acetylcholine receptor scaffolds and structural 
proteins, components of the immune system, and phosphatidylinositol signalling inter 
alia. Viral proteins are also homologous to members of the oestrogen, peroxisome 
proliferator, and CREB activated receptor networks, all of which are implicated in 
prostate cancer, and to a protein, SRCAP, that controls the expression of the prostate-
specific antigen. These short matches are often predicted to be antigenic, and 
antibodies to XMRV proteins may target their human homologues. This is supported 
by the presence of autoantibodies to muscarinic receptors , vimentin and LAMINB1 
(all XMRV homologues) in chronic fatigue syndrome sufferers. Homologous XMRV 
proteins might also interfere with the protein interactomes of their human 
homologues. Viral mimicry of human proteins is extensive and often relevant to 
disease. For example Epstein-Barr viral proteins aligns with multiple sclerosis 
autoantigens, while HIV-1 proteins align with several components of the immune 
system. Mutant proteins in Huntington’s disease and cystic fibrosis also align with 
proteins from common phages or viruses. This suggests a common theme of viral 
derived autoimmunity/network interference in many human disorders, which could 
radically change the shape of future therapy. Such viral mimicry likely relates to the 
idea that life evolved from viruses, leaving behind a legacy of viral derived human 
proteins whose homology to the current virome may be responsible for many human 
diseases and syndromes. Vaccination programmes or immunosuppression may be 




 Chronic fatigue syndrome is an unexplained medical condition characterised 
by extreme mental and physical fatigue 25. and by cognitive impairment, depression 
and muscular pain and excessive sensitivity to light, sound and smell 41. The condition 
has a very high prevalence, for example a figure of 30% of the general population was 
recently reported in a study from the Netherlands 46 and there are as many as four 
million sufferers in the USA. 7 Perhaps most of the population will experience this 
condition at some time in their lives. It may be triggered by infection or trauma or by 
vaccination against hepatitis b 33 or against multiple infectious agents (suggested as 
the cause of Gulf War syndrome31,49) . The syndrome appears to have an autoimmune 
component and antibodies to silicone, squalene , muscarinic receptors and nuclear 




































 The syndrome  is treated by low dose antidepressants which are palliative at 
best 48, has been considered as a psychiatric phenomenon 47 and can indeed benefit 
from cognitive therapy 49. The lack of effective therapy has encouraged the use of 
alternative medicine whose effectiveness remains to be verified by the scientific 
community 49. Many studies have linked viral infection to the syndrome and 
implicated the cytomegalovirus, the Epstein-Barr virus,  human herpes virus 6 and 7 , 
hepatitis C, an intestinal enterovirus , the Nipah virus and parvovirus B19 
5,10,11,15,32,42,49. Microbial infections are also common in these patients 52, 
 Perhaps the most intensively studied and hotly debated 21 viral cause of chronic 
fatigue syndrome is the XMRV retrovirus (Xenotropic murine leukemia virus-related 
virus) initially reported by Lombardi and colleagues 24. This  virus has also been 
implicated in prostate cancer 4. As shown below, this virus expresses proteins which 
are homologous to several human proteins which are relevant to all of the symptoms 





 A homology search between the XMRV genome (NC_007815.1) or the 
XMRV proteins  and human proteins  (blastx; nucleotide search vs proteins or Blastp; 
protein vs protein) was undertaken using the NCBI server 2. Only proteins with 
matches containing pentapeptide strings were included, except in the case of longer 
strings with few gaps or where several contiguous strings were identified. The results 
in Tables 1-10 record the position of the match within the viral genome or viral 
protein and the position within the matching human proteins, (whose DNA will also 
evidently match that of the viral genome)   Accession numbers and a brief definition 
of function, as recorded in Entrez gene are provided. The B-cell immunogenecity of 
different amino acids was calculated using the B-epitope prediction server (Bepipred) 
23 http://www.cbs.dtu.dk/services/BepiPred/ 





 XMRV proteins are homologous to a variety of human proteins as shown in 
Table 1-10. Perhaps the most relevant in relation to fatigue are the mitochondrial 
proteins involved in respiration and oxidative phosphorylation (eg ATP801, COX11) 
(Table 1, Fig 1). Glutamate is the primary excitatory brain neurotransmitter and 
XMRV homology to the AMPA receptor GRIA4 and to members of the presynaptic 
(Bassoon, piccolo)  and postsynaptic machinery (DLGAP3)might also contribute to 
cognitive defects (Table 2, Fig 1) as might members of the phosphatidylinositol, 
phosphodiesterase  and Rho signalling networks  (Table 3, Fig 1).. The muscular pain 
experienced by chronic fatigue sufferers might well be related to homology with 
proteins involved in acetylcholine receptor scaffolding (Table 2, Fig 1) and to 
structural muscle elements (Table 4, Fig 1, and the sensitivity to smell to homology 
with several olfactory receptors (Table 2 , Fig 1). 
 XMRV proteins are also homologous to proteins of the growth factor signalling 
networks (e.g. tyrosine kinases FLT3 and TYRO3) (Table 5) which are relevant to 




































They are also homologous to the TAP1 and TAP2 antigen transporter and to a number 
of immunoglobulins and cytokine-related proteins (Table 6, Fig 2).  
Other classes involved include a number of  proteins related to nuclear receptors, 
several of which (oestrogen and PPAR receptors and CREB) are directly implicated in 
prostate cancer 6,30,50, and to a protein (SRCAP) that controls the expression of the 
prostate-specific antigen the 39 ,marker for prostate cancer (Table 7, Fig 2) . Other 
homologous classes include transcription factors (Table 8, Fig 2),adhesion molecules 
(Table 9, Fig 1 and 2) , proteases and protein processors (Table 11) and a number of 
miscellaneous or unknown proteins (Table 13).  
 Some of the viral translated genome matches to human proteins do not appear 
to relate to any known XMRV protein (certain olfactory receptors the phosphatase 
PPAPDC2 and the phosphodiesterase ENPP6). This may be related to viral open 
reading frames that have not yet been characterised , for example a new ORF has just 
been described for the cytomagalovirus 29 , or that may shift with mutation. However 
in these cases viral DNA remains homologous to that of the human target. 
 Different amino acids have different antigenicity depending on their charge 
and hydrophobicity characteristics and the B-epitope antigenicity index for each 
amino acid is shown in Table 14 23. It should be noted that such indices can change 
markedly depending on the number of amino acids in the contiguous string or on the 
identity of the neighbouring amino acids. Marked synergy exists when antigenic 
amino acids form contiguous stretches. This individual index serves as a rough gauge 
of the antigenic potential of the peptide. The top 5 antigenic amino acids are marked 
with an asterisk in the various tables, and contiguous antigenic amino acids, which are 
the most likely epitope and cross-reactive candidates, are highlighted in grey. It can 
be seen that a number of matching proteins are predicted to be highly antigenic.  
These include the mitochondrial proteins CHCHD10 ,acetyl CoA carboxylase and the 
sulfite oxidase SUOX, (Table 1), the glutamate receptor GRIA4  (Table 2)  the TBCC 
tumour suppressor (Table 7) numerous growth regulators (FLT3, TYRO3,WNT10B 
and  EIF4B ) (Table 5) the antigen transporter TAP1 (Table 6)  the PPAR and 
oestrogen receptor and PSA regulators, PELP1, PPRC1 and SRCAP (Table 7), the 
transcription factor FOXO6 (Table 8) , pleckstrin 3 (Table 9) the metalloprotease 





 The XMRV virus expresses predicted proteins with homology to human 
proteins that are clearly highly relevant to the symptoms encountered in this disease, 
including fatigue  (mitochondrial respiration), cognitive deficits 49 (glutamate, PI 
signalling) problems related to olfaction 41(olfactory receptors) muscular pain 41 
(acetylcholine receptor and muscle related structural proteins) and the association 
with many active viral and microbial infections 19 (immune related proteins).  
.XMRV viral proteins are also highly homologous to components of peroxisome 
proliferator-activated receptor gamma (PPARG) or oestrogen receptor signalling 
networks both of which have been implicated in prostate cancer 6,30 A viral protein is 
also homologous to SRCAP which controls the expression of the prostate specific 
antigen, the cardinal marker of prostate cancer39.  
 Although these matching strings are short, they are often contiguous and the 
viral homologues may interfere with their human counterparts in a number of ways. 




































virus may also target the human homologues. Indeed autoantibodies to muscarinic 
receptors, cellular cytoskeletal components, including vimentin and other Lamina 
related proteins and  to  nuclear envelope proteins including Lamin A and LAMIN B1 
have been reported in chronic fatigue syndrome    22,44. These were all identified as 
XMRV homologues in this survey (specifically muscarinic receptor, CHRM2, Lamin 
B1 and Vimentin and generally the cytoskeletal components in Table 4). 
Viral DNA will also match that of the human target and possibly sequester host 
transcription factors or microRNA of influence splicing of the homologous human 
gene.  
 These homologies, targeted at highly relevant proteins support the implication 
of the virus in both chronic fatigue syndrome and prostate cancer. 
 Several studies have failed to detect the virus in chronic fatigue syndrome and 
the issue is hotly debated 14,21,28.  Because the viral proteins are homologous to human 
proteins, it is likely that any anybodies generated in response to the virus would target 
their human homologues. This is supported by the high predicted antigenicity of a 
number of viral matching proteins and by the presence of autoantibodies to viral 
matching proteins in chronic fatigue sufferers.  As the human proteins are persistently 
encountered by the antibody, such an autoimmune response would become self-
sustaining, thus no longer requiring the presence of the virus. Indeed, the more 
successful the immune response against the virus, the greater the risk of 
autoimmunity, a disastrous pyrrhic victory. This scenario could thus explain the 
failure to detect the virus in several studies. 
 It has recently been shown that Raltegravir potently inhibits XMRV 
replication and clinical trials in chronic fatigue syndrome and prostate cancer have 
already been proposed 38 a suggestion supported by the results of this survey. 
However, it is possible that the effects of the virus, in the form of autoimmunity 
persist after viral elimination and different strategies including immunosuppression 
might be considered in such cases.  
 Viral mimicry of human proteins appears to be a near universal phenomenon. 
For example several viruses (almost 100), including those implicated in late-onset 
Alzheimer’s disease, express proteins that are homologous to beta-amyloid .The 
autoantigens in multiple sclerosis, myasthenia gravis, systemic lupus erythromatosus, 
Pemphigus Vulgaris and Sjogrens syndrome align with proteins from their respective 
reported viral risk factors (and novel suspects), and HIV-1 proteins align with 
important components from all compartments of the human immune system. This 
even applies to human genetic disorders, as the APP mutations in Alzheimer’s disease 
convert the surrounding peptide to sequences that match proteins from commensal 
bacteria and from the Norovirus and common cold virus. The mutant proteins in 
Huntington’s disease and cystic fibrosis also align with proteins expressed by very 
common viruses or phages 8,9. This suggests that a large number of diseases have an 
autoimmune component triggered by viral antigens with homology to important 
human proteins.     
 Viruses or phages were long ago proposed as the origin of life 13,17. While 
responsible for our existence, they appear to have left behind a legacy of viral derived 
human proteins containing short but contiguous and often immunogenic amino acid 
stretches homologous to current viral antigens.  The autoimmune defence so triggered 
may be responsible for a large number of human illnesses. The therapeutic 
implications of such mimicry are clearly extensive as it suggests an autoimmune 
component in a variety of disorders which might thus benefit from vaccination against 










































Table 1 to 10 
 
Human proteins that match proteins from the translated XMRV genome. The 
alignment is shown and accession numbers are provided together with a brief 
description of the function of the protein. Unless specifically referenced, these are 
copied from the gene descriptions in ENTREZ gene. The matching peptide sequence 
in each case is highlighted in bold and contiguous amino acids of 5 or more or longer 
stretches of contiguity with few gaps are boxed. The asterisks represent the 5 highest 
scoring antigenic amino acids (Table 14) and the grey highlights illustrate contiguous 





































Table 1: Human mitochondrial and energy related proteins with homology to XMRV proteins 
 
Human protein Alignment with the translated XMRV Genome and equivalent viral protein Gene symbol and 
comments 
AAI09318.1  ATP8A1 protein  Query  172  GSGSIQGATPGGRCNPL-VLEFTDAGKRASWDAPKTWG-
LRLYRSTGADPVT  221 (ENV) 
             S*  I       R   L VLE*FT-A-KR S*        G*-LRLY   G*AD* V  
Sbjct  510  DSVIIDSLGQEERYELLNVLEFTSARKRMSVIVRTPSGKLRLY-
CKGADTVI  560 
ATP8A1 
The protein encoded 
by this gene is a 
member of the third 
subfamily of P-type 





EAW79217.1  ATPase, Ca++ 
transporting, type 2C, member 1, 
isoform CRA_a [Homo 
Query  569  QG*WFE*G*LFNRS*---
P*WFTTLIS*TIMG*P*LIVLLLILLFG*P*CILNRLVQFVKD*RIS*------  619 
            +G*W E*  F+ S*   P*     IS*    P*LI LLL       +   L +   D* +S*       
Sbjct  92   HG*WNE*--FD*IS*E*D*E*P*LWKKYIS*QFKNP*LIMLLL----
AS*AVIS*VLMHQFD*D*AVS*ITVAIL  145 
And  
Query  622  QALVLTQQ----YHQLKS*  635 
            Q-L-LTQQ    Y+Q K  





hydrolysis of ATP 
coupled with the 
transport of calcium. 
 
XMRV=ENV 
NP_998885 coiled coil helix coiled 
coil helix domain containing protein 
10, mitochondrial precursor 
Query--6543--P*P*P*S*G*AAS*MVP*G*AP*P*P*S*QQP*G*--6605 (Genome) 
P*P*P*S* -AA---P*-A P*-P*S*-QP*G*   
Subjct—27----P*P*P*S*AAA---P*-AP*AP*S*G*QP*G*--43 
CHCHD10 ?  
XMRV =ENV 







































































sulfite oxidase  
 
            E*P*P*P*E*  
Sbjct  543  EPPPE  547 
Catalyzes the oxidation 
of sulfite to sulfate, the 
final reaction in the 
oxidative degradation 
of the sulfur amino 
acids cysteine and 
methionine. Sulfite 
oxidase deficiency 
results in neurological 
abnormalities. XMRV 
= GAG-POL-PRO
NP_005006 oxidase (cytochrome c) 
assembly 1-like OXA1L  
Query  436  RQLRE  440 
            RQLRE* 
Sbjct  955  RQLRE  959 
And Query  464  NPLLQPGKDNPPNI---PSSSSKPKS  486 
             P*L     ++P*P*     P*S*S*S*      
Sbjct  151  GPLIDLLTEDPPPYGAQPSSSARENN  176 
OXA1L 
OXA1 is a 
mitochondrial inner 
membrane insertase, 
mediates the insertion 
of  mitochondrial- and 
nuclear-encoded 
proteins from the 




 EAW94549 COX11 homolog, 
cytochrome c oxidase assembly prot 
 
 
Query  1306   
D*LYNWKNNN------P*S*FS*ED*P*G*KLTALIES*V-LI-----
THQP*TWD*D*CQQLLG*TLLT (Genome) 
D*LYNWK         P*             E* V LI     TH P*TW   Q-------------------------------------------
---------TLLT 
Subjct  19    D*LYNWKS*HS*KG*LWVS*P*R------------
COX11 (Oxidative 
phosphorylation): 
Cytochrome c oxidase 
(COX) is the terminal 











































































chain.COX11 is not a 
structural subunit, but 
may be involved in 
COX formation 
XMRV = GAG and  
EAW94547.1  COX11 homolog, 
cytochrome c oxidase assembly 
protein (yeast), 
Query  602  FG*P*CILNRLVQFVKD*R  617 (ENV) 
            FG*P*CI-N     V FV  R 




AAH62437.1  Cytochrome c 
oxidase subunit IV isoform 1  
Query  417  LVE*LWP*KVTYHS*P*NYVYG*---Q-FE*K  438 
            LV +W K       YVYG*   Q F+K 
Sbjct  116  LVIMWQK------HYVYG*P*LP*QS*FD*K  135 
COX4I1 
encodes subunit IV 




NP_942131 acetyl CoA carboxylase 
1 isoform 1  
Query--5402--YRIS*-----YG*VS*P*WG*--5370 (Genome) 
YRI------ YG*VS*P*WG*   
Subjct--508---YRIKD*IRMMYG*VS*P*WG*--523 
ACACA 
ATP + acetyl-CoA + 
HCO3- = ADP + 
phosphate + malonyl-
CoA XMRV = GAG-
PRO-POL 
EAW59424 ATPase, H+ 


















































































Table 2: Glutamate and other receptors and channels and pre- and post-synaptic scaffolds 
 




NP_003449.2  protein 
bassoon  
Query  204   PKTWG--LRLYRSTGADPVTLFSLTRQVLNVGPRVPIGP  240 (ENV) 
 
             P   G   R Y S G   V-L-SLTR-V   + PRVP-GP 
Sbjct  2218  PMVRGGMYRPYASGGITAVPLTSLTR-VPMIAPRVPLGP  2255  
Query  260   RTPRPPPSGAASMVPGAPPPS  280 
              TP P P       PGAP PS  
Sbjct  1507  QTPSPAPASDMPRSPGAPTPS  1527 
BSN 
Essential for regulating 
neurotransmitter release from 




NP_149015 protein piccolo 
isoform 1  
Query--6498--P*P*S*QP*VQIMLP*RTP*RP*P*P*--S*G*AA---S*MVP*G*-
AP*P*P*S*QQP*G*--6605 (Genome) 










AAI46817-GRIA4-protein- Query  628  WFFTLI  633 
            WF TLI 
Sbjct  581  WFTTLI  586 
And  
uery  594  GIFN-SLWFS  602 
            G FN S* WF  
Sbjct  574  GLFNRSPWFT  583 
GRIA4 Glutamate 




XMRV = ENV 
NP_001070711.2|  
glutamate receptor 4 isoform 2 
precursor 
Query  584  GPSDQPP  590 
















































































DLGAP3 Part of the post-
synaptic density anchoring 
glutamate receptors and 
channels XMRV Not found 
in proteins 




Query  548  RD*S*MAKLRE*---
RLNQRQKLFE*S*G*QG*WFE*G*LFNRS*P*WFTTLIS*TIMG*P*LIVLLLILLFG*P*  
604 
             + + K  E*      QR K  +                  L  T-MG*P*LI            
Sbjct  297  KE*ILD*KFTE*E*VVKQTQRIKIG*D*P*----------------
LLE*D*TRMG*P*LI--------NR  332 
 
ALDH9A1 








and muscle related 
  
NP_001006631.1   muscarinic 
acetylcholine receptor M2 
Query  245  NNNMPS-SDD  253 
            NNN PS S+D 
Sbjct  238  NNN-PSFSED  246 
 And 
Query  87    GYWPL-G-PV  94 
             GYW L G PV 
Sbjct  1362  GYWVLQGKPV  1371 
 
Query  355   DEKQ  358 
             DEKQ 








































































Query  441  ALCNATFKKT  450 
            ALCN T K   
Sbjct  370  ALCNTTQKTS  379 
XMRV=ENV 














UTRN Controls acetylcholine 
receptor clustering 
XMRV =ENV





MAGI2 Interacts with 
atrophin-1 and with 
components of the post-
synaptic density 
XMRV =GAG  




Query  460  GHATALIQSL  469 
            G  TALI+S*  
Sbjct  248  GKLTALIESV  257 
And   
Query  70   GPRG  73 
            GPRG 
Sbjct  521  GPRG  524 
And  
Query  33   QQPPPPP  39 
            Q+P*P*P*-P* 
Sbjct  542  QEPPPEP  548 
 
HCN2 







































































EAW73220.1  mucolipin 2, 
isoform CRA_b  
Query  627  TQQYHQLKS*I  636 
            T- QYHQLK-I  
Sbjct  49   TTQYHQLKD*I  58 
MCOLN2 
cation channel with homology 
to the transient receptor 
potential superfamily 
XMRV=ENV 
EAW96452.1  ATP-binding 
cassette, sub-family C 
(CFTR/MRP), member 9, 
isoform 
Query  1496  LE*--D*IFP*RF-------G*MP*Q  1507 
             LE*  D*IFP*RF       G*MP*+ 
Sbjct  144   LE*S*KD*IFP*RFKP*FTD*AVG*MP*H  164 
ABCC9 
This protein is thought to form 
ATP-sensitive potassium 
channels in cardiac, skeletal, 
and vascular and non-vascular 
smooth muscle. 
XMRV= GAG-PRO-POL 
Olfactory and taste receptors   
Q8NGU4 OR2I1_HUMAN 
RecName: Full=Putative 





XMRV Not found in 
proteins 
NP_001005466 olfactory 





XMRV Not found in 
proteins 
NP_001001802 olfactory 





XMRV Not found in 
proteins 
AAM19327.1 AF494236_1 
candidate taste receptor 
TAS2R49  
Query  43   NVTWKI--------TNL  
            NVTWKI          NL 






specific protein 1  
Query  423  RE*AE*KIFNKRE*TP*E*E*RE*E*RIRRE*IE*E*KE*-E*RRR-----AE*D*-
--E*Q------RE*RE*---R  464 










































































Sbjct  212  RE*AE*--F------E*AE*QE*RIRRE*-




































































































Table 3: Inositol phosphate, phosphodiesterase and RAB signalling 
 
Human protein Alignment with the translated XMRV Genome Gene symbol and comments 
EAW58785 phosphatidic acid 




PPAPDC2 presqualene diphosphate 
phosphatase XMRV Not found in 
proteins 
NP_055459 myomegalin isoform 1  Query--7398--D*S*MAKLRERLNQRQ—7439 (Genome) 
D*- MAKLRE*-L-Q-Q 
Subjct--309---D*TMAKLREMLHQS*Q—322 
PDE4DIP: Interacts with PDE4D a 
3',5'-cyclic-AMP phosphodiesterase 
that degrades cAMP, which acts as 
a signal transduction molecule in 









XMRV Not found in proteins 
AAH32848 RHOBTB1 protein  Query--1976--QRMSREREKGTAED*I—2020 (Genome) 
Q--RERE*K---E*D*I 
Sbjct—664---QRVKREREK---ED*I—675 
RHOBTB1: The protein plays a 
role in small GTPase-mediated 
signal transduction and the 
organization of the actin filament 
















































































Table 4 Cytoskeletal and structural elements 
 
Human protein Alignment with the translated XMRV Genome Gene symbol and 
comments 
Muscle related   
EAW99062 dystrophin 
(muscular dystrophy, 




DMD Bridges the 
cytoskelon and the 
extracellular matrix 
XMRV = ENV
AAH81563 FHOD3 protein  Query--4555--EAA----MKAVLETSTLLIED*STP*--4614 (Genome) 







EAX01379.1  formin 
homology 2 domain containing 
3, isoform CRA_a  
Query  1309  AD*QAARE*AAMKAVLE*TS*TLLIE*D*S*TP*  1334 (Genome) 
             A+ AA    MKAVL-TS*    +E*D* TP* 




EAW71838.1  myosin, heavy 
polypeptide 14  
Query  508   LS*E*VVLQ---NRR  517 
             L-E*VVLQ    RR 




CAI14818 tubulin folding 





suppressor in breast 
cancer cells 16 
XMRV = GAG
AAH58938 LZTS2 protein  Query--2847--TLP*VP*LEHAP*--AT—2882 (Genome) 
TLP*VP*LE* -AP*--AT 
Sbjct--6-----TLP*VP*LEP*AP*EAAT—19 
LZTS2 A tumor 
suppressor also 
implicated in the 








































































synaptic density 35 
XMRV Not found 
in protein
Query  294   LGSGTRAS  301 
             L S*G*TR   
Sbjct  1563  LASGTRDW  1570 
And  
Query  494  GLQEAARA  501 
            G*LQ A R  
Sbjct  338  GLQNAGRS  345 
 
And  
Query  573   AQVERL  578 
              QVER+ 
Sbjct  1545  GQVERM  1550 
Query  315  PPPPP  319 
            P*P*P* P* 
Sbjct  544  PPPEP  548 
XMRV= POL 
AAH31000.1  PHLDB2 
protein pleckstrin homology-
like domain, family B, 
member 2  
Query  439  E*E*RIRRE*IE*E*KE*E*RRRAE*D*E*--QR----E*RE*---RD*RRR  468 
            E*E*  RRE*I E*K     R ++E*  QR    E* E*   R+R R 
Sbjct  11   E*E*KRRRE*ILE*K----RLQE*E*TS*QRQKLIE*KE*VKIRE*RQR  45 
PHLBD2 Involved 






EAW53237.1  tropomyosin 3, 
isoform CRA_h  
Query  436  E*E*RE*E*RIRRE*IE*E*KE*E*RR-R--AE*D*E*  458 
            E*E*R E*R--RE*+E*    E*RR R  AE* E* 
Sbjct  25   E*E*RAE*RLQRE*VE*--G*E*RRARE*QAE*AE*  48 
XMRV=  
TPM3 : Family of 
actin-binding 
proteins involved in 
the contractile 











































































ABV48785.1  troponin T type 
2 cardiac  
Query  451  E*RRRAE*--D*E*QR---E*RE*RD*R  466 
            E*RRRAE*   ++QR   E*RE* +R 














XMRV = ENV 




subunit alpha-5; AltName: 
Full=Laminin-10 
Query  115   G*HTVLTG*CG*G*P*RE*G*YCG*  
             G*H    G*CG*G* R ---CG* 
 
Query  175   S*IQG*ATP*G*G*RCNP*  187 
                   P*G*G*RC+P*  






AAD03694.1  dynactin 1 Query  264   P*P*P*S*G*AAS*MVP*G*AP*P*P*S*QQP*G*T  285 
             P*P*P*S*G*-A +V G*     QQ G*  





















































































NP_057726.3  spectrin beta 
chain, brain 4  
Query  632   QLKS*ID*P*E*E*V  641 
             QLK--D*P*E*E*V  







Query  433  LVDT---HSKRT  441 
            LVD*T   HS*  T 
Sbjct  562  LVDTGAQHSVLT  573 
And  
uery  135  LEQLKGQGKSRLGDL  149 
            LE LK      LGDL 
Sbjct  410  LEDLKSKT---LGDL  421 
 
And  
Query  257   DVDVSKPDLT  266 
             +     P*D*LT 
Sbjct  1158  ETHGTRPDLT  1167 
And Query  441   TLLI  444 
             TLLI 
Sbjct  1326  TLLI  1329 
 
VIM 







Nuclear envelope   
1203377A lamin A Query  97   RS*P*G*G*RKRTRLYD*FYV-
CP*G*HTVLTG*CG*G*P*RE*G*YCG*KWG*CE*TTG*QA  141 
            RS*P*G*G*R     L  F   C G*H  L  CG*G*        WG* +  G*Q  
Sbjct  604  RS*P*G*G*RTHL-LWLFCLQCHG*HS*QLP*QCG*G*Q-------WG*WQLRG*QS*  
641 
LMNA 
Lamin proteins are 
thought to be 













































































    lamin-B1 
Query  456  LKNTSEQDQPMGGWEMIRKIGDTSVSYKYTSR-------------YVLKAGQ  494 
            L  TS*E*QD*    G   +    G+    Y                  Y LK GQ 
Sbjct  885  LAATSEQDCQRGTRALLQTLGN—LGYRASAKKAQICQKQVKYLGYLLKEGQ 
 
And  
Query  493  GQTVTI  498 
            G*QTVT   
Sbjct  2    GQTVTT  7 
And  
Query  163  LEDLK  167 
            LE*D*LK 
Sbjct  410  LEDLK  414 
LMNB1 
Lamin proteins are 
thought to be 
involved in nuclear 
stability, chromatin 























































































Table 5 Tyrosine kinases, growth factor signalling and translation initiation 
 























inhibitor 1  
Query  1416  PPPPPPPQQP  1425 
             P*  P*P*P*-QQP* 
Sbjct  274   PGAPPPSQQP  283 
And  
Query  844  NTTVLN  849 
             TTVLN 
Sbjct  404  STTVLN  409 
 
And  
Query  532  GSCSVTC  538 
              CS*VT  
Sbjct  339  ANCSVTS  345 
 And  
Query  1088  EGGL  1091 
BAI1: BAI1 is 
postulated to be a 















































































             E*G*G*L 





Query  1404  PEAPPAQPP  1412 
             P*  P* AQP*P* 
Sbjct  103   PPGPSAQPP  111 
And  
Query  1161  RSALFQIL  1168 
             RS*AL+  L 
Sbjct  113   RSALYPAL  120 






















IGFL2: F amily 
of signaling 
molecules that 
play critical roles 
in cellular energy 




prenatal growth  
XMRV= GAG-
PRO-POL 
   
EAW80747.1  
dishevelled 
Query  458  E*QRE*RE*RD*RRRHRE*  471 













































































Sbjct  450  E*QRE*RE*RKMRKAKE*  463 The protein 
encoded by this 
gene contains FH 
domains and 
belongs to a novel 
FH protein 
subfamily 
implicated in cell 
polarity. Wnt/Fz 
signaling 
activates the small 
GTPase Rho, a 













Query  252  QP*VQIMLP*RTP*RP*P*P*S*G*AAS*MVP*G*AP*P*P*S*QQP*  283 
            QP*     P*RTP*RP*P*     A + P*G*   P*   P* 























































































be involved in 
breast cancer, and 
its protein 
















is reduced in the 
epithelium of 
prostate cancers 
during benign and 
malignant 
transformation 51 









by the products of 
the growth arrest-
specific gene 6 
and protein S 















































































found in protein 
Query  268  PFAYGVQ  274 
            P* YG*VQ 
Sbjct  161  PPPYGVQ  167 
And  
Query  114  EESQQVWL  121 
            E*E* Q V L 
Sbjct  279  EEKQRVLL  286 
XMRV = GAG 
Query  38   IKLKVSQGQPVKL  50 
            I LKV  G*QPV   
Sbjct  550  ITLKVG-GQPVTF  561 
And  
Query  639  IHRDLA  644 
             HRDLA 







receptor Edg5  
Query  221  ADMAAP  226 
            A+MAAP 
Sbjct  975  AEMAAP  980 
and 
Query  229   LALLK  233 
             LALLK 
Sbjct  1275  LALLK  1279 
And  
















































































             H+ YT ET 





Query  119   SVFSLL  124 
             S*VF LL 














proposed to be 




found in protein 
Query  183  RNHLCLVFELL  193 
            RNHL L  +LL 
Sbjct  325  RNHLVLYRQLL  335 
And  
Query  21   QVLPD  25 
            QVLP*D* 




EIF3A protein  
Query  423  RE*AE*KIFNKRE*TP*E*E*RE*E*R-----IRRE*IE*E*KE*E*R-------RRAE*D*E*-------QRE*RE*  463 
             E* + I   R+T-E*E*R-E*R      I RE*-E*E*-E*+R       R AE*+E*       +RE* E* 




































































































roles as master 
switches in cell 
cycle control 
XMRV Not 































































































Table 6 Proteins related to the Immune system 
 
Human protein Alignment with the translated XMRV Genome Gene symbol and 
comments 
Antigen transport   
NP_000584.2  antigen peptide 
transporter 1  
Query  223  LP*RTP*RP*P*P*S*G*  268 
                    L RTP*R P*P*S*G*  











transporter XMRV = 
GAG 
Immunoglobulins and related   
ACS95245.1  immunoglobulin 
heavy chain variable region  
Query  614  VKD*RIS*VVQALVLTQQYHQLKS*ID*P*E*E*  640 (ENV) 
            VK-RIS*V        Q   QLKS*+ P*E*+ 





BAC01352 immunoglobulin heavy 
chain VHDJ region  
Query--7118--G*RTYYG*RHSCRS-WNRD*YSP*S—7177 (Genome) 
G*RTYY -----RS*- W-RD*Y-P*S*  
Sbjct--51----G*RTYY-----RSTWYRD*YAP*S—66 
IGHG1 
XMRV Not found in 
protein 
AAF21617AF019642_1 Ig heavy 
chain  
Query--7118--G*RTYYG*RHSCRS-WNRD*YSP*S—7177 (Genome) 
G*RTYY -----RS*- W+-D*Y-P*S*  
Sbjct--48----G*RTYY-----RSKWD*SD*YAP*S—63 
IGH 
XMRV Not found in 
protein 
ABW80020.1  immunoglobulin 
heavy chain variable region  
Query  81  VG*D*NWD*D*  87 










































































Sbjct  83  VG*E*NWD*D*  89 
And  
Query  129  YCG*KWG*CE*TTG*QAYWKP*S*S*S*WD*  150 
            YC K      G*  Y   S*S*S*WD* 







CP*AHC ---- C-C-E*E*AL 
Sbjct--206--CP*AHC----C-CP*EEAL—217 
ILDR1 
XMRV Not found in 
protein 
CAM25666 HLA B associated 




BAT5 Possible role in 
immunity 
XMRV Not found in 
protein 









Putative interleukin 17 
receptor IL17 The is a 
proinflammatory 
cytokine produced by 
activated T cells. 
XMRV Not found in 
protein








survival in vitro and is 
a regulator of the 
peripheral B-cell 








































































AAC51498.1  T-cell receptor delta 
chain  
Query  458  E*QRE*RE*RD*RRRHRE*  471 
            E*QRE*RE*R    R   E* 
Sbjct  417  E*QRE*RE*RKMRKAKE*  430 
TCRD@ 
T cell receptor 
XMRV=ENV  
Other   
ABQ53140 lactoperoxidase variant  Query--4028--P*CSP*YR--------KRKP*P*M-TASRS---WL—4084 (Genome) 
P*CS*P*YR ---------RKP*-+--A-R----WL 
Sbjct--51----P*CSP*YRTITG*D*CNNRRKP*ALG*AANRALARWL—81 








LP*P*S*------- P*R-P*-P*P*P*S* ---------P*P*P* 
Sbjct--23----QELP*P*S-------P*RSP*SP*P*P*S---------P*P*P*--40 
NCCRP1 ? 
XMRV = ENV 
AAH96211 PRB3 Protein  Query--1220--P*QRTP*P*P*P*--1243 (Genome) 
P*QRTP*P*P*P*  
Sbjct--47----P*QRTP*P*P*P*--54 
PRB3 : proline-rich 
salivary protein is a 
major constituent of 
parotid saliva. This 
protein is proposed to 
act as a bacterial 
receptor. XMRV Not 
found in protein 
NP_000615.3  plasma serine 
protease inhibitor  
Query  773  RE*VNKRVE*D*IH--P*TV  786 
            RE*  KRVE*D*-H   TV 
Sbjct  25   RE*MKKRVE*D*LHVG*ATV  40 
SERPINA5 : Possesses  
bactericidal activity 27 
XMRV= GAG-PRO-
POL
EAW59717.1  Hermansky-Pudlak 
syndrome 4, isoform CRA_a  
Query  243  VITE*QLP*P*S*QP*VQIMLP*RTP*----RP*P*P*S*G*AAS*MVP*G*AP*-
P*P*S*QQ  282 
            ++  QLP*P*S*     ++L RT     R P*  G* A    G*A  P*P*  Q 
Sbjct  195  
IVS*TQLP*P*S*LTAKVLLHRTAP*QE*QRLP*TG*G*D*AP*QE*HG*AALP*P*NVQ  
HPS4 
The protein encoded 
by this gene appears to 
be important in 











































































































































































Table 7 : Nuclear receptors and related 
 




proline , glutamic 
acid  and leucine 
rich protein 1 






















Query  87    ALGALV------SLSNARLS  100 
             A  ALV       LS*NAR+  













































































































































































































































Skin specific  
Query  553  KVG*G*QP*VTFLVD*TG*AQHS*VLTQNP*------G*P*LS*D*KS*AW---VQG*ATG*G*KRYRWTT-
D*RK  602 
            K+G*  P*V-FLVD * G*AQ S*V   N       G* L         V  A G*         D*   
Sbjct  68   
KIG*KVP*VRFLVD*S*G*AQVS*VVHP*NLWE*E*VTD*G*D*LD*TLQP*FE*NVVKVANG*AE*MKILG*VW














Query  404  S*TTVLNLTTD*YCVLVE*LW  421 
            S*  V   TT-YCVLV--W 











Query  476  ATKQFE*QL  483 






























































































ros oncogene 1 , 
receptor tyrosine 
kinase 
Query  434   
G*QFE*KKTKYKRE*P*VS*LTLALLLG*G*LTMG*G*IAAG*VG*TG*TTALVATKQFE*QLQAAIHTD*LG*A  
493 
              + E*    + RE*   LTL-LLLG*    G* +  G*                    I       
Sbjct  1932  E*E*IE*NLP*AFP*RE*--KLTLRLLLG*S*G*AFG*E*VYE*G*TAVD*ILG*VG*S*--------















Query  293   VE*G*AYLALNLTS*P*D*KT  308 
             VE*  YLALN     D*KT 



























































































Query  553  KLRE*RLNQRQKLFE*  566 
            K RE*   QRQKL-E*  
Sbjct  96   KIRE*K--QRQKLLE*  107 
DDX55 
implicated in 






























































































protein 2  
Query  261   TP*RP*P*P*S*----G*-AAS*M--VP*G*AP*P*P*  279 
             T-RP*P*P*S*     G* AA M  VP* AP* P* 









Query  553   KLRE*RLNQRQK-LFE*S*G*QG*WFE*G*--LFNRS*P*WFTTLI  586 
             KLRE*R   +RQK   E*  +       LF  S*P*     I 
Sbjct  1157  KLRE*RFCHRQKE*VS*E*E*NHNHHNE*RMLFHG*S*P*FINAII  1193 
TNKS : Plays 






2BQ0 A Chain A, 
14-3-3 Protein 
Beta (Human) 
Query  1307  RMAD*QAAR----E*AAMKAVLE*  1323 
              +A+QA R     AAMKAV-E*  







that it may 


















































































X breakpoint 2  
Query  440  E*RI--R---RE*IE*E*KE*E*RR  453 
            E* I  R   RE* + E*KE*E*RR  

































































































Table 8: Transcription factors  
Human protein Alignment with the translated XMRV Genome Gene symbol and 
comments 
XP_002342143 PREDICTED: 





FOXO6: FOXO’s are 
relevant to cancer by 
virtue of their pro-
apoptotic effects and 
ability to promote cell 
cycle arrest 26 XMRV 
Not found in protein
EAW49709.1  paired-like 
homeodomain transcription factor 
3, isoform CRA_a 
Query  231  NVGPRVPIGPNPVITEQLPPSQPVQIMLPRTPRPPPSG-
AASMVPGAPPPSQQPGT  285 
            NVG*P*             L  S*QP*V          P*P*S*  AAS*MVP*-A       P*G*T 
Sbjct  62   NVGP-------------LA-SQPV--------FSPPSSIAASMVPSAAAA---PGT  
92 
PITX3 







Transforming growth factor beta 1 





QLP*-S*Q---P*VQ-----TP*----------- P*G*AP*P*P*-QQ  
Sbjct--604---QLP*YSQAAP*P*VQ-----TP*----------LP*G*AP*P*P*-QQ—626 
TSC22D1: encodes a 
transcription factor and 
belongs to the large 
family of early 
response genes XMRV 
= ENV
NP_005465 histone deacetylase 5 




HDAC5: Histones play 
a role in transcriptional 











































































structure and affects 
transcription factor 
access to DNA. 
































































































Table 9. Adhesion and related 
 
Human protein Alignment with the translated XMRV Genome Gene symbol and 
comments 
NP_001005389 neurofascin isoform 
5 precursor  
Query--2623--WYHVANTHLLCLLSALAG*AV-----P*SVP*QP*EL—2540 (Genome) 
W-H-A--- LLCLLS*-L-G*A+ -----P*S*+-Q-E*L 
Sbjct--9-----WVHAA--FLLCLLS-LG*G*AIEIP*MD*P*SI-QNEL—37 
NFASC: Involved in 
node of Ranvier 
formation XMRV = 
ENV 






Susceptibility gene for 
sarcoidosis  20a 
condition associated 
with chronic fatigue 12 
XMRV = GAG







function of specific 
cell-cell neural 
connections” XMRV 
Not found in protein
Q7Z736PKHH3_HUMAN 












ITGB4 Expression is 
reduced in prostate 
cancer  1 











































































Table 10: Protein cleavage , processing and sorting 
Human protein Alignment with the translated XMRV Genome or Specified proteins Gene symbol and 
comments 




? XMRV Not found 
in protein 






NP_060043 proprotein convertase 





PCSK4 Substrates for 
these enzymes range 
from prohormones to 
precursors for growth 
factors to cell surface 
receptors and viral 
surface glycoproteins 
XMRV Not found in 
protein





F8 Coagulation factor. 
The coagulation 
pathway is activated 
in chronic fatigue 
syndrome 18  
XMRV = GAG







































































P*P*P*S*-----VP*--- P*-S*Q+P*G*-G*--L  
Sbjct--373---P*P*P*S--VNRVP*P*SSP*SSQEP*G*SG*QP*L--396 
link the ubiquitination 
machinery to the 
proteasome to affect 
in vivo protein 
degradation. XMRV - 
ENV
3IU1A Chain A, Crystal Structure 





NMT1: Myristate is  
attached by  amide 
linkage to the N-
terminal glycine 
residue of cellular and 
viral proteins with 
diverse functions. N-
myristoyltransferase  
catalyzes the transfer 
of myristate from 
CoA to proteins. 
XMRV =GAG










Members of the 
ADAMTS family 
have been implicated 
in the cleavage of 
proteoglycans, the 
control of organ shape 
during development, 
and the inhibition of 
angiogenesis XMRV 







































































Table 10 Miscellaneous /Unknown function  
 
Human protein Alignment with the translated XMRV Genome Gene symbol and 
comments 
NP_056487 RIMS binding Protein 
3A  
Query--363--RP*-----QP*WETSQRP*--395 (GAG) 
RP*----- QP*WE*TS*Q-P*  
Sbjct--698--RP*G*HP*P*EQP*WETSQMP*--713 
RIMBP3  ? 
XMRV =GAG 







threaten the integrity 
of genetic material in 
cells. Some lesions 
escape repair and 
block the replication 
machinery. Members 
of the Y family of 
DNA polymerases, 
such as POLK, permit 
the continuity of the 
replication fork by 
allowing replication 
through such DNA 
lesions. XMRV = 
ENV






XMRV Not found in 
protein 
CAI17641 SCAN domain 














































































AAH63121 OSBP Protein  




OSBP : Oxysterol 
binding protein is an 
intracellular protein 
that is believed to 
transport sterols from 
lysosomes to the 
nucleus where the 
sterol down-regulates 
the genes for the LDL 
receptor, HMG-CoA 
reductase, and HMG 
synthetase XMRV Not 
found in protein
EAX09281 Pericentrin (kendrin), 
isoform CRA_e  
Query  482  QLQ---AAIHTDLGALE-KSVSALEKSLTS--LSEVVLQ-----
NRRGLDLL  522 (ENV Protein) 
            +LQ   AA   DLGALE    S L+ SL S  LSE   Q      R  L+LL 
Sbjct  948  ELQTKHAA---DLGALETRHLSSLD-SLESCYLSE--
FQTIREEHRQALELL  993 
 
 
PCNT : binds to 
calmodulin and is 
expressed in the 
centrosome. It is an 








XMRV Not found in 
protein 
NP_055616 Pecanex like Protein 2  Query--5428--FHD*P*EMSKLTNS—5463 (Genome) 










































































NP_775922.2  fibrous sheath-
interacting protein 2  
Query  403  IG*RKLE*RLE*D*LKS*KTLG*D*LVRE*AE*KIFNKRE*TP*E*E*--
-----RE*E*R-----------IRR  444  
            I RKLE*-LE*            R          T E*E*       RE*E*R            RR  
Sbjct  300  IS*RKLE*QLE*-----------R----------
TAE*E*QRLFLMD*RE*E*RRQRE*HTRRKLTLRR  338  
 
Query  445  E*IE*E*KE*E*R---------RRAE*D*E*QRE*RE*R---D*RRRHRE*  471
  
             I E* E*E*          R AE*D*  RE* E*R      R RE*  
Sbjct  339  KIE*--E*E*WKTKE*MLLLTRMAE*D*VKRE*-




NP_660348 solute carrier family 25 


















































































Table 11: The B-cell epitope antigenicity prediction indices for individual amino 
acids 
The five highest scoring amino acids are highlighted and are marked by an asterisk in 
the various tables. 
 
Symbol Amino acid 
B-epitope 
antigenicity
P Proline  0.145
G Glycine  0.035
D Aspartate 0.018
E Glutamate 0.003
S Serine  -0.008
T Threonine  -0.011
Q Glutamine  -0.012
N Asparagine  -0.013
A  Alanine -0.024
W Tryptophan  -0.025
K Lysine  -0.031
R Arginine  -0.062
H Histidine  -0.071
V Valine  -0.112
F Phenylalanine  -0.138
I Isoleucine  -0.138
M Methionine  -0.138































































Figure 1: The localisation of the viral/human protein matches related to mitochondria, 
central neurotransmission, the muscular system and the olfactory network. PI = 
phosphatidylinositol, PD = phosphodiesterase. See Tables for definitions, 
 
 
Figure 2: The localisation of the viral/human protein matches in relation to 
transcription factors, tyrosine kinase and growth related pathways, prostate cancer 
protein processing, transporters and the immune system. Underlined genes marked 
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